ELAN vs PAHC
ELAN: Elanco is a pure-play animal health leader focused on innovating treatments and wellness solutions for pets and livestock worldwide. PAHC: Phibro Animal Health is a diversified global provider of animal health and nutritional solutions for livestock and companion animals, supplemented by a specialty chemicals business.
Side-by-side fundamentals
| Metric | ELAN | PAHC | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $22.54 | $37.40 | |
| Market cap | $11.3B | $1.5B | |
| P/E as of 2026-10-08 | n/a | 16.07 | |
| Net margin | -4.9% | +6.6% | PAHC higher |
| Gross margin | +55.0% | +33.8% | ELAN higher |
| Operating margin FY2026, SEC XBRL | n/a | +12.8% | |
| ROE | -3.5% | +25.9% | PAHC higher |
| ROA | -1.7% | +6.6% | PAHC higher |
| Debt / equity as of 2026-09-03 | 0.59 | 2.03 | ELAN lower |
| Revenue growth (YoY) as of 2026-09-03 | +11.9% | +26.0% | PAHC higher |
| Revenue CAGR (3y) SEC XBRL | +2.2% | +15.8% | PAHC higher |
| Dividend yield as of 2026-09-02 | n/a | +1.4% | |
| Dividend streak (yrs) SEC XBRL | 0 | 12 | PAHC higher |
| Beta as of 2026-09-03 | 1.26 | 1.06 | |
| 1-year return as of 2026-10-08 close | +10.8% | +0.8% | ELAN higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.